138 results on '"Bergner, Amanda"'
Search Results
2. Comparing the frequency of variants of uncertain significance (VUS) between ancestry groups in a paediatric epilepsy cohort.
3. Individuals' experiences in genetic counseling and predictive testing for familial amyotrophic lateral sclerosis
4. Exploring the evolving roles of clinical geneticists and genetic counselors in the era of genomic medicine.
5. Genetic counselors' utilization of ChatGPT in professional practice: A cross‐sectional study.
6. Patient-reported outcomes of pain and physical functioning in neurofibromatosis clinical trials
7. Patient experiences in receiving telegenetics care for inherited cardiovascular diseases
8. Genetic counselors' utilization of ChatGPT in professional practice: A cross‐sectional study
9. Telegenetics in cardiovascular disease: patient experience and follow-up care
10. Knowledge and beliefs about epilepsy genetics among Hispanic and non‐Hispanic patients
11. Neurofibromatosis
12. Tuberous Sclerosis
13. Overview of Neurocutaneous Syndromes
14. Clinical utility of exome sequencing in a pediatric epilepsy cohort
15. The utility of limited Spanish proficiency in interpreted genetic counseling sessions
16. P395: Assessing the collaborative relationships among diverse stakeholders working to expand access to genetic services in Puerto Rico
17. Enrolling Genomics Research Participants through a Clinical Setting: the Impact of Existing Clinical Relationships on Informed Consent and Expectations for Return of Research Results
18. The Dynamics of a Genetic Counseling Peer Supervision Group
19. 2013 Review and Update of the Genetic Counseling Practice Based Competencies by a Task Force of the Accreditation Council for Genetic Counseling
20. Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation
21. Genetic testing for the epilepsies: A systematic review
22. A report of the AGCPD task force to evaluate associations between select admissions requirements, demographics, and performance on ABGC certification examination
23. Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas
24. Overview of Neurocutaneous Syndromes
25. Neurofibromatosis
26. Tuberous Sclerosis
27. Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
28. The evolution of genetic counseling graduate education in New York City during the COVID‐19 pandemic: In the eye of the storm
29. Informed consent for exome sequencing research in families with genetic disease: The emerging issue of incidental findings
30. A report of the AGCPD task force to evaluate associations between select admissions requirements, demographics, and performance on ABGC certification examination.
31. Increased risk of breast cancer in women with NF1
32. Genetic testing for the epilepsies: A systematic review.
33. Metanephric Stromal Tumor Arising in a Patient With Neurofibromatosis Type I Syndrome
34. Genetic Counseling for Neurofibromatosis 1, Neurofibromatosis 2, and Schwannomatosis—Practice Resource of the National Society of Genetic Counselors
35. Reflections on diversity, equity, and inclusion in genetic counseling education
36. Mutation analysis of B3GALTL in Peters Plus syndrome
37. Improvement in Patient-reported Hearing After Treatment With Bevacizumab in People With Neurofibromatosis Type 2
38. EPID-16. HEREDITARY BRAIN TUMORS ARE MORE COMMON THAN YOU THINK: GERMLINE MUTATIONS IN BENIGN AND MALIGNANT PRIMARY BRAIN TUMORS
39. Improving the molecular diagnosis and treatment of epilepsy with complex genetic testing
40. Molecular diagnosis for neurodevelopmental disorders-an overview of multi-gene panels and whole exome sequencing (P3.211)
41. Germline genetic mutations contribute to the development of primary brain tumors: a review of a multigene panel testing cohort (S41.008)
42. Choices for return of primary and secondary genomic research results of 790 members of families with Mendelian disease
43. MNGO-13. GERMLINE MUTATIONS IN INDIVIDUALS WITH MENINGIOMA AND BREAST CANCER
44. The Dynamics of a Genetic Counseling Peer Supervision Group
45. Health-related Quality of Life of Individuals With Neurofibromatosis Type 2
46. Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2–Associated Vestibular Schwannomas
47. Bevacizumab Impact on Hearing Loss Due to Neurofibromatosis Type 2 Associated Vestibular Schwannomas and Associated Biomarkers (S34.004)
48. Enrolling Genomics Research Participants through a Clinical Setting: the Impact of Existing Clinical Relationships on Informed Consent and Expectations for Return of Research Results.
49. Dystrophic Spinal Deformities in a Neurofibromatosis Type 1 Murine Model
50. Incidental parenchymal magnetic resonance imaging findings in the brains of patients with neurofibromatosis type 2
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.